Australia is closely awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://lawsonzscu068865.blogs-service.com/73969929/this-new-drug-retatrutide-australia-a-potential-breakthrough-for-losing-weight